Article PDF first page preview

First page of Physical Assessment of Congestion and Perfusion Status in Heart Failure

BACKGROUND: Clinical profiles based on congestion and perfusion are fundamental to the management of patients with heart failure (HF), but the standard assessment has been underutilized in clinical practice, due in part to its complexity. This study investigated whether congestion and perfusion status by physical examination, such as high jugular venous pressure (JVP) and peripheral cold sensation, would be informative in this context. METHODS: This prospective study consisted of 257 patients who were admitted for the treatment of HF. A body-to-peripheral temperature gradient and the presence or absence of peripheral cold sensation were assessed before discharge. JVP was considered high if visible pulsation of the internal jugular vein was observed in the seated position at rest or with inspiration, and categorized as wet. The primary outcome was a composite of all-cause death and hospitalization for worsening HF. RESULTS: A total of 132 patients (51.3%) were classified as cold on the peripheral sensation, with a higher temperature gradient (9.0 ± 1.8ºC) than patients without peripheral cold sensation (4.8 ± 1.7ºC, p <0.01). On JVP assessment, 54 patients (21.0%) were classified as wet. During a mean follow-up period of 446 ± 280 days, 109 patients experienced a primary outcome event. The presence of peripheral cold sensation and wet condition were associated with a higher incidence of the primary outcome (hazard ratio, 1.70 and 1.62; 95% confidence interval, 1.14 to 2.52 and 1.04 to 2.52; both p <0.01, respectively). The status of congestion and perfusion based on the standard classification and our simple physical method using peripheral sensation and JVP assessment showed similar trends in the incidence of the primary outcome at one year. CONCLUSIONS: Physical assessment of congestion and perfusion status based on the presence or absence of peripheral cold sensation and wet condition by JVP assessment was practical and useful for the risk stratification of patients with HF.

Journal Section:
HF and Intensive Care
This content is only available via PDF.
S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2025
You do not currently have access to this content.